Mengis Capital Management, Inc. Abb Vie Inc. Transaction History

Mengis Capital Management, Inc.

$497 Million
Q3 2024

A detailed history of Mengis Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 9,023 shares of ABBV stock, worth $1.72 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

9,023

Previous 8,908 1.29%

Holding current value

$1.72 Million

Previous $1.53 Million 16.63%

% of portfolio

0.36%

Previous 0.31%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$163.84 - $199.33 $18,841 - $22,922	115 Added 1.29%	9,023 $1.78 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $30,958 - $36,152	-200 Reduced 2.2%	8,908 $1.53 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $31,964 - $36,420	200 Added 2.25%	9,108 $1.66 Million
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $133 - $154	1 Added 0.01%	8,908 $1.33 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $39,753 - $49,470	-300 Reduced 3.26%	8,907 $1.2 Million
Q1 2023 May 05, 2023	BUY	$144.61 - $166.54 $26,029 - $29,977	180 Added 1.99%	9,207 $1.47 Million
Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $29,045 - $34,832	-210 Reduced 2.27%	9,027 $1.46 Million
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $17,313 - $19,856	-129 Reduced 1.38%	9,237 $1.24 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $9,633 - $12,247	-70 Reduced 0.74%	9,366 $1.43 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $72,589 - $90,062	-550 Reduced 5.51%	9,436 $1.53 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $3,375 - $3,716	33 Added 0.33%	9,986 $1.08 Million
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $67,048 - $90,522	833 Added 9.13%	9,953 $1.07 Million
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $1,116 - $1,310	-13 Reduced 0.14%	9,120 $798,000
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $161,634 - $216,290	2,203 Added 31.79%	9,133 $896,000
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $1,612 - $2,444	-25 Reduced 0.36%	6,930 $527,000
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $522,942 - $654,312	-7,250 Reduced 51.04%	6,955 $615,000
Q3 2019 Nov 05, 2019	SELL	$62.98 - $75.72 $1.81 Million - $2.17 Million	-28,716 Reduced 66.9%	14,205 $1.08 Million
Q2 2019 Jul 18, 2019	BUY	$65.7 - $83.98 $2.1 Million - $2.68 Million	31,946 Added 291.08%	42,921 $3.12 Million
Q1 2019 May 06, 2019	SELL	$77.14 - $90.79 $51,683 - $60,829	-670 Reduced 5.75%	10,975 $884,000
Q4 2018 Feb 06, 2019	SELL	$77.85 - $96.01 $70,065 - $86,409	-900 Reduced 7.17%	11,645 $1.07 Million
Q3 2018 Nov 05, 2018	SELL	$88.91 - $98.84 $168,929 - $187,796	-1,900 Reduced 13.15%	12,545 $1.19 Million
Q2 2018 Jul 24, 2018	SELL	$89.78 - $106.23 $53,868 - $63,738	-600 Reduced 3.99%	14,445 $1.34 Million
Q1 2018 Apr 27, 2018	BUY	$92.01 - $123.21 $27,603 - $36,963	300 Added 2.03%	15,045 $1.42 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $4,478 - $4,910	-50 Reduced 0.34%	14,745 $1.43 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $1.03 Million - $1.32 Million	14,795	14,795 $1.31 Million

Others Institutions Holding ABBV

# of Institutions

3,894

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $336B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mengis Capital Management, Inc. with notifications on news.

Account

Mengis Capital Management, Inc. Abb Vie Inc. Transaction History